How many drugs treat Diabetic peripheral neuropathy?

Drug Landscape tracks 2 marketed treatments for Diabetic peripheral neuropathy (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/diabetic-peripheral-neuropathy.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Diabetic peripheral neuropathy — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diabetic peripheral neuropathy (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Diabetic peripheral neuropathy, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Cymbalta	duloxetine	Eli Lilly and Company	Serotonin and norepinephrine reuptake inhibitor (SNRI)	Serotonin and norepinephrine reuptake		2004-08-03
Tarlige	MIROGABALIN	Daiichi Sankyo		Voltage-dependent calcium channel subunit alpha-2/delta-1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Daiichi Sankyo · 1 drug in Diabetic peripheral neuropathy
Eli Lilly and Company · 1 drug in Diabetic peripheral neuropathy

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Diabetic peripheral neuropathy:

Cite this brief

Drug Landscape (2026). Diabetic peripheral neuropathy — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/diabetic-peripheral-neuropathy. Accessed 2026-06-10.

Diabetic peripheral neuropathy full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing